好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Financial and Mental Health Burden on Caregivers of Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD) in the United States
Autoimmune Neurology
P3 - Poster Session 3 (5:00 PM-6:00 PM)
1-007

This analysis of caregivers for patients with NMOSD assessed income losses associated with caregiving for patients with versus without a reported relapse, financial tradeoffs, and mental health burdens.

NMOSD is a rare autoimmune disease characterized by repeated, unpredictable relapses, often leading to irreversible neurological disability. In a survey, 53% of patients with NMOSD reported needing a caregiver.

Unpaired patient and caregiver respondents completed an electronic survey (January-April 2024) of demographics, relationship to caregiver/patient, and costs for 2023. Impacts on caregivers’ income, employment, educational opportunities, and mental health were evaluated. Record linkage was used to integrate patient characteristics (eg, age, ≥1 relapse in 2023) by pairing a patient respondent with each caregiver respondent based on their description of the individual for whom they provided care.

Of 49 caregiver respondents (mean±SD age, 42.1±13.6 years; mean±SD weekly caregiving time, 39.7±23.3 hours), most were employed full-time (57.1%) and reported a household income <$100,000 (52%). Caregivers linked to patients with a relapse lost ~$171 more weekly per hour of caregiving than caregivers linked to patients without a relapse, amounting to an average income loss of $7079/year. Providing >35 hours/week of care was associated with an increased likelihood of occupational change; 25% of caregivers reported that NMOSD influenced their decision to stop working/retire. Of caregivers for patients aged >45 years, 26% reported lost educational opportunities due to caregiving. Caregivers aged <40 years reported more frequent loss of personal identity and mistrust of other caregivers or disproportionate sense of responsibility compared with caregivers aged >40 years.

Caregivers linked to patients with NMOSD with a relapse reported increased earning loss due to care responsibilities compared with caregivers of patients without a relapse, suggesting treatments that are effective in preventing relapses could reduce caregiver burden. Additionally, caregivers experience a substantial burden on their employment, educational opportunities, and mental health.

Authors/Disclosures
Evanthia Bernitsas, MD, FAAN (Wayne State School of Medicine)
PRESENTER
Dr. Bernitsas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Bernitsas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vanda. The institution of Dr. Bernitsas has received research support from Roche/Genentech.
Mayvis Rebeira, PhD Ms. Rebeira has received personal compensation for serving as an employee of Alexion.
Roc Reguant, PhD Dr. Reguant has received personal compensation for serving as an employee of Alexion.
Jesus Loreto, Caregiver Mr. Loreto has nothing to disclose.
Jamie Sullivan, MPH Ms. Sullivan has received personal compensation for serving as an employee of EveryLife Foundation for Rare Diseases. An immediate family member of Ms. Sullivan has received personal compensation for serving as an employee of Takeda. Ms. Sullivan has received personal compensation in the range of $5,000-$9,999 for serving as a Policy Advisor with COPD Foundation.
Elizabeth Crevier, MPH Mrs. Crevier has received personal compensation for serving as an employee of Avalere Health.
Ashleeashlee J. Olsenolsen Miss Olsenolsen has nothing to disclose.
Benjamin J. Osborne, MD, FAAN (Medstar Georgetown University Hospital) Dr. Osborne has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Osborne has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Osborne has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Osborne has received publishing royalties from a publication relating to health care.